Účtovná hodnota akcie spoločnosti Theratechnologies
Aká je hodnota metriky Účtovná hodnota akcie spoločnosti Theratechnologies?
Hodnota metriky Účtovná hodnota akcie spoločnosti Theratechnologies Inc. je 0.16
Aká je definícia metriky Účtovná hodnota akcie?
Účtovná hodnota akcie (Book/Share) sa rovná majetku spoločnosti mínus záväzky spoločnosti podelené počtom vydaných akcií.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Účtovná hodnota akcie spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Theratechnologies
Čomu sa venuje spoločnosť Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Firmy s metrikou účtovná hodnota akcie podobnou spoločnosti Theratechnologies
- Hodnota metriky Účtovná hodnota akcie spoločnosti China City Infrastructure je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Healthcare Merger je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti FinServ Acquisition Corp je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Sezzle je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti ZincX Resources je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Dingdong (Cayman) Ltd je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Theratechnologies je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Vivos Therapeutics je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Tritent International je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Garibaldi Resources je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Fujian je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Nova Minerals je 0.16
- Hodnota metriky Účtovná hodnota akcie spoločnosti Kwan Yong je 0.16